Table 2 Baseline characteristics per comorbidity cluster.
Characteristics | Overall (n = 3697) | SSD comorbidity patterns | Statistical Value | P value | |||
|---|---|---|---|---|---|---|---|
SSD only (n = 2880) | High-risk metabolic multisystem disorders cluster (n = 39) | Low-risk metabolic multisystem disorders cluster (n = 573) | Sleep disorders cluster (n = 205) | ||||
Gender | |||||||
Female | 1756 (47.50) | 1342 (46.60) | 21 (53.85) | 273 (47.64) | 120 (58.54) | 11.59a | 0.010* |
Male | 1941 (52.50) | 1538 (53.40) | 18 (46.15) | 300 (52.36) | 85 (41.46) | ||
Marital status | |||||||
Married | 2296 (62.10) | 1836 (63.75) | 25 (64.10) | 344 (60.03) | 91 (44.39) | 37.71a | <0.001* |
Single | 1117 (30.21) | 827 (28.72) | 8 (20.51) | 188 (32.81) | 94 (45.85) | ||
Divorced/Widowed | 284 (7.68) | 217 (7.53) | 6 (15.38) | 41 (7.16) | 20 (9.76) | ||
Work status | |||||||
Blue-Collar | 3084 (83.42) | 2428 (84.31) | 31 (79.49) | 453 (79.06) | 172 (83.90) | –b | <0.001* |
White-Collar | 264 (7.14) | 201 (6.98) | 4 (10.26) | 47 (8.20) | 12 (5.85) | ||
Unemployed | 244 (6.60) | 178 (6.18) | 2 (5.13) | 47 (8.20) | 17 (8.29) | ||
Retired | 105 (2.84) | 73 (2.53) | 2 (5.13) | 26 (4.54) | 4 (1.95) | ||
Age group | |||||||
≤25 | 469 (12.69) | 375 (13.02) | 1 (2.56) | 59 (10.30) | 34 (16.59) | –b | <0.001* |
26–39 | 1142 (30.89) | 901 (31.28) | 3 (7.69) | 167 (29.14) | 71 (34.63) | ||
40–59 | 1753 (47.42) | 1365 (47.40) | 17 (43.59) | 280 (48.87) | 91 (44.39) | ||
≥60 | 333 (9.01) | 239 (8.30) | 18 (46.15) | 67 (11.69) | 9 (4.39) | ||
Ethnic group | |||||||
Minority | 696 (18.83) | 571 (19.83) | 7 (17.95) | 98 (17.10) | 20 (9.76) | 14.05a | 0.006* |
Han | 3001 (81.17) | 2309 (80.17) | 32 (82.05) | 475 (82.90) | 185 (90.24) | ||
Educational | |||||||
Primary and below | 1959 (52.99) | 1552 (53.89) | 10 (25.64) | 294 (51.31) | 103 (50.24) | –b | |
Secondary School | 1493 (40.38) | 1140 (39.58) | 25 (64.10) | 239 (41.71) | 89 (43.41) | <0.001* | |
Higher Education | 245 (6.63) | 188 (6.53) | 4 (10.26) | 40 (6.98) | 13 (6.34) | ||
Payment | |||||||
Rural Residents (Insurance) | 902 (24.40) | 901 (31.28) | 0 (0) | 1 (0.17) | 0 (0) | –b | <0.001* |
Urban And Rural Residents (Insurance) | 2711 (73.33) | 1907 (66.22) | 38 (97.44) | 566 (98.78) | 200 (97.56) | ||
Self-Pay | 84 (2.27) | 72 (2.50) | 1 (2.56) | 6 (1.05) | 5 (2.44) | ||
Admission count | |||||||
1 | 1852 (50.09) | 1485 (51.56) | 17 (43.59) | 249 (43.46) | 101 (49.27) | 18.62a | 0.003* |
1–2 | 1110 (30.02) | 856 (29.72) | 15 (38.46) | 183 (31.94) | 56 (27.32) | ||
≥3 | 735 (19.88) | 539 (18.72) | 7 (17.95) | 141 (24.61) | 48 (23.41) | ||
Length of hospital stay, day | 53.00 (28.00, 64.00) | 54.00 (29.00, 63.00) | 50.00 (26.50, 54.00) | 51.00 (28.00, 65.00) | 53.00 (29.00, 76.00) | 4.50c | 0.092 |
Blood groups | |||||||
AB | 317 (8.57) | 248 (8.61) | 3 (7.69) | 47 (8.20) | 19 (9.27) | –b | <0.001* |
A | 1073 (29.02) | 864 (30.00) | 4 (10.26) | 140 (24.43) | 65 (31.71) | ||
B | 809 (21.88) | 652 (22.64) | 5 (12.82) | 116 (20.24) | 36 (17.56) | ||
O | 987 (26.70) | 770 (26.74) | 4 (10.26) | 142 (24.78) | 71 (34.63) | ||
Unknown | 511 (13.82) | 346 (12.01) | 23 (58.97) | 128 (22.34) | 14 (6.83) | ||
Lipid metabolism metrics | |||||||
Total cholesterol, mmol/L | 4.25 (3.63, 4.95) | 4.22 (3.63, 4.96) | 4.28 (3.54, 4.95) | 4.32 (3.68, 4.93) | 4.18 (3.60, 4.90) | 1.30c | 0.728 |
Triglyceride, mmol/L | 1.24 (0.90, 1.84) | 1.25 (0.89, 1.86) | 1.03 (0.81, 1.71) | 1.27 (0.92, 1.83) | 1.12 (0.85, 1.54) | 7.59c | 0.055 |
High-density lipoprotein cholesterol, mmol/L | 1.14 (0.94, 1.35) | 1.14 (0.92, 1.36) | 1.17 ± 0.28 | 1.14 (0.97, 1.33) | 1.11 (0.94, 1.36) | 0.24c | 0.972 |
Low Density lipoprotein cholesterol, mmol/L | 2.57 (2.10, 3.15) | 2.51 (2.04, 3.14) | 2.85 (2.42, 3.25) | 2.70 (2.16, 3.20) | 2.52 (2.09, 3.07) | 16.16c | 0.001* |
Free Fatty Acids, mmol/L | 0.36 (0.26, 0.60) | 0.35 (0.26, 0.62) | 0.36 (0.24, 0.62) | 0.36 (0.26, 0.60) | 0.35 (0.25, 0.54) | 1.58c | 0.664 |
Apolipoprotein AI, g/L | 1.28 (1.13, 1.49) | 1.28 (1.12, 1.51) | 1.22 ± 0.21 | 1.28 (1.13, 1.47) | 1.36 (1.17, 1.50) | 9.14c | 0.028* |
Apolipoprotein B, g/L | 0.72 (0.61, 0.84) | 0.73 (0.64, 0.82) | 0.86 (0.69, 1.04) | 0.72 (0.60, 0.88) | 0.67 (0.51, 0.78) | 19.60c | <0.001* |
Apolipoprotein A, mg/L | 11.75 (4.77, 37.52) | 10.15 (4.20, 28.45) | 52.80 (35.60, 141.00) | 14.00 (5.40, 47.70) | 10.15 (4.38, 30.40) | 41.40c | <0.001* |
Systemic inflammation metrics | |||||||
Red blood cell, 1012/L | 4.71 (4.37, 5.06) | 4.68 (4.35, 5.03) | 4.75 ± 0.57 | 4.75 (4.38, 5.09) | 4.85 ± 0.60 | 10.25c | 0.017* |
Hemoglobin, g/L | 141.00 (131.00, 154.00) | 141.00 (130.00, 154.00) | 142.59 ± 16.00 | 142.00 (132.00, 154.00) | 146.20 ± 16.96 | 12.33c | 0.006* |
Hematocrit, % | 42.00 (39.00, 46.00) | 42.00 (39.00, 46.00) | 0.43 (0.40, 0.49) | 41.00 (6.17, 45.00) | 44.00 (41.00, 47.00) | 112.58c | <0.001* |
Mean corpuscular volume, fl | 90.70 (87.80, 93.70) | 90.70 (87.90, 93.70) | 89.91 ± 4.63 | 90.60 (87.60, 93.90) | 90.65 (87.70, 93.82) | 1.59c | 0.661 |
Mean Corpuscular Hemoglobin, pg | 30.30 (29.20, 31.50) | 30.30 (29.10, 31.40) | 30.16 ± 2.24 | 30.30 (29.20, 31.50) | 30.55 (29.40, 31.80) | 2.10c | 0.551 |
Mean corpuscular hemoglobin concentration, g/L | 333.00 (328.00, 340.00) | 333.00 (327.00, 339.00) | 335.14 ± 12.15 | 334.00 (328.00, 340.00) | 334.97 ± 9.47 | 7.94c | 0.047* |
Red Cell Distribution Width Coefficient of Variation, % | 11.70 (11.20, 12.40) | 11.70 (11.20, 12.20) | 13.15 ± 0.82 | 12.00 (11.50, 12.80) | 11.60 (11.10, 11.93) | 107.03c | <0.001* |
Platelet, 109/L | 219.00 (181.00, 263.00) | 218.00 (177.00, 262.00) | 219.27 ± 47.67 | 219.00 (185.00, 267.00) | 224.98 ± 64.67 | 1.32c | 0.724 |
Platelet distribution width, fl | 17.00 (16.30, 17.60) | 17.20 (16.60, 17.80) | 12.80 ± 2.48 | 16.70 (12.80, 17.40) | 17.15 (16.70, 17.60) | 136.13c | <0.001* |
Mean platelet volume, fl | 9.50 (8.40, 10.60) | 9.40 (8.30, 10.50) | 10.41 ± 1.28 | 9.70 (8.70, 10.80) | 9.00 (8.07, 10.30) | 31.87c | <0.001* |
Plateletcrit, % | 0.20 (0.17, 0.24) | 0.20 (0.17, 0.24) | 0.23 ± 0.05 | 0.21 (0.18, 0.25) | 0.20 (0.16, 0.23) | 21.22c | <0.001* |
Red Cell Distribution Width - Standard Deviation, fl | 42.60 (40.40, 45.10) | 42.50 (40.30, 45.00) | 43.52 ± 3.09 | 42.60 (40.25, 45.12) | 41.50 ± 3.04 | 1.99c | 0.575 |
Platelet-larger cell ratio, % | 27.75 (21.33, 33.18) | 27.70 (20.90, 33.10) | 29.69 ± 8.10 | 27.50 (21.45, 33.10) | 24.77 ± 3.25 | 2.38c | 0.497 |
white blood cell, 109/L | 6.40 (5.30, 7.70) | 6.30 (5.20, 7.60) | 6.57 ± 1.81 | 6.50 (5.40, 7.96) | 6.80 (5.70, 8.22) | 18.03c | <0.001* |
Neutrophil percentage, % | 65.15 ± 10.18 | 65.22 ± 10.02 | 61.18 ± 11.81 | 64.24 ± 10.52 | 68.02 ± 9.36 | 7.78 d | <0.001* |
Lymphocyte percentage, % | 25.80 (19.80, 32.15) | 25.70 (19.90, 32.50) | 28.74 ± 10.45 | 26.95 ± 9.42 | 23.80 ± 8.44 | 15.10c | 0.002* |
Monocytes percentage, % | 6.80 (5.70, 8.00) | 6.80 (5.70, 8.00) | 7.26 ± 1.67 | 6.90 (5.80, 8.10) | 6.90 (5.70, 7.93) | 1.32c | 0.724 |
Eosinophil percentage, % | 1.00 (0.55, 1.70) | 1.00 (0.60, 1.60) | 2.00 (0.70, 3.00) | 1.00 (0.50, 1.90) | 0.80 (0.40, 1.25) | 20.72c | <0.001* |
Basophil percentage, % | 0.20 (0.20, 0.30) | 0.20 (0.10, 0.30) | 0.50 (0.30, 0.70) | 0.20 (0.20, 0.40) | 0.20 (0.10, 0.20) | 78.70c | <0.001* |
Absolute neutrophil count, 109/L | 4.10 (3.20, 5.30) | 4.00 (3.19, 5.20) | 4.05 ± 1.45 | 4.10 (3.17, 5.50) | 4.50 (3.68, 5.80) | 18.32c | <0.001* |
Absolute lymphocytes count, 109/L | 1.60 (1.22, 2.06) | 1.60 (1.20, 2.00) | 1.80 (1.30, 2.29) | 1.70 (1.30, 2.17) | 1.60 (1.20, 1.90) | 19.05c | <0.001* |
Absolute monocyte count, 109/l | 0.40 (0.34, 0.52) | 0.40 (0.30, 0.50) | 0.48 ± 0.17 | 0.43 (0.38, 0.57) | 0.50 (0.40, 0.60) | 11.32c | 0.010* |
Absolute eosinophil count, 109/L | 0.10 (0.00, 0.10) | 0.10 (0.00, 0.10) | 0.10 (0.03, 0.19) | 0.10 (0.00, 0.10) | 0.10 (0.00, 0.10) | 22.09c | <0.001* |
Absolute basophil count, 109/L | 0.00 (0.00, 0.00) | 0.00 (0.00, 0.00) | 0.03 (0.02, 0.05) | 0.00 (0.00, 0.03) | 0.00 (0.00, 0.00) | 248.67c | <0.001* |
Antistreptolysin O, IU/ml | 55.20 (32.60, 101.90) | 56.10 (35.20, 98.88) | 369.80(245.45, 494.15) | 51.15 (29.98, 113.45) | 51.00 (25.90, 110.70) | 6.02c | 0.111 |
Rheumatoid factor, IU/ml | 5.00 (3.00, 8.00) | 5.00 (3.00, 8.00) | 0.80(0.50, 1.10) | 4.40 (2.80, 8.00) | 4.00 (2.70, 7.00) | 11.45c | 0.010* |
C-reactive protein, mg/L | 1.60 (0.60, 3.50) | 1.90 (0.88, 3.90) | 2.15 (1.80, 4.67) | 1.50 (0.52, 3.30) | 1.30 (0.60, 2.80) | 5.15c | 0.161 |
Serum amyloid A, mg/L | 5.20 (3.10, 8.95) | 6.10 (4.38, 12.63) | 9.81 ± 11.57 | 4.90 (3.02, 9.25) | 3.90 (2.95, 6.80) | 8.89c | 0.031* |
Monocyte to high-density lipoprotein cholesterol ratio | 0.40 (0.29, 0.54) | 0.40 (0.29, 0.54) | 0.49 ± 0.22 | 0.38 (0.28, 0.51) | 0.43 (0.36, 0.59) | 6.42c | 0.093 |
Monocyte-to-lymphocyte ratio | 0.27 (0.21, 0.36) | 0.27 (0.21, 0.36) | 0.28 (0.21, 0.33) | 0.26 (0.20, 0.34) | 0.30 (0.23, 0.39) | 11.23c | 0.011* |
Platelet-to-lymphocyte ratio | 133.82 (101.57, 178.89) | 135.62 (102.00, 183.12) | 125.61 (95.44, 162.77) | 129.22 (98.19, 166.92) | 136.34 (107.06, 189.39) | 9.54c | 0.023* |
Neutrophil-to-lymphocyte ratio | 2.56 (1.81, 3.64) | 2.56 (1.81, 3.62) | 2.07 (1.60, 3.61) | 2.46 (1.74, 3.44) | 2.92 (2.07, 4.39) | 18.11c | <0.001* |
Systemic immune-inflammation index | 547.08 (369.26, 835.27) | 548.84 (365.22, 814.27) | 481.96 (343.45, 746.26) | 529.71 (353.11, 810.14) | 611.08 (434.84, 1003.79) | 13.03c | 0.005* |
System inflammation response index | 1.11 (0.73, 1.73) | 1.10 (0.72, 1.69) | 1.08 (0.74, 1.45) | 1.07 (0.71, 1.74) | 1.26 (0.89, 2.10) | 16.30c | <0.001* |
Aggregate index of systemic inflammation | 239.50 (150.18, 397.53) | 234.65 (148.37, 386.26) | 249.38 (162.33, 331.15) | 233.39 (140.18, 399.84) | 281.19 (184.49, 471.69) | 12.55c | 0.006* |
Derived neutrophil to lymphocyte ratio | 1.91 (1.41, 2.62) | 1.90 (1.42, 2.62) | 1.52 (1.26, 2.46) | 1.88 (1.35, 2.47) | 2.14 (1.61, 3.07) | 19.50c | <0.001* |